The Pharmaceutical Journal
Vol 272 No 7291 p348
20 March 2004

This article
Reprint
Photocopy

PDF* 70K, Acrobat Reader

· Community pharmacy
· Obesity
· Prescription fraud
· ADR reporting
· Careers supplement

Letters to the Editor

Obesity

The role of syrup in medicines should be examined

From Mr H. R. Patel, FRPharmS

From all recent accounts in the media, obesity is a growing problem. Is it time, therefore, to reduce or eliminate the use of syrup in medicines and in particular for chronic therapy like methadone treatment? For someone on, say, 100ml of methadone a day, the amount of sugar consumed must easily exceed or make up a substantial part of the total daily energy needs. If we are going to tackle obesity in the population, the role of syrup in medicines must also be examined since it could be contributing to the problem.

Hemant Patel
Brentwood, Essex

Send your letter to The Editor

Previous Topic (Community pharmacy)
Next Topic (Prescription fraud)